An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age
Authors:
- The Belgian Diabetes RegistryTRThe Belgian Diabetes Registry
- I. WeetsIWI. Weets
- O. CostaOCO. Costa
- K. VerhaeghenKVK. Verhaeghen
- D. G. PipeleersDPD. G. Pipeleers
- 18 November 2011
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 55 (2) , 413-420
Abstract
Aims/hypothesis The appearance of autoantibodies (Abs) before diabetes onset has mainly been studied in young children. However, most patients develop type 1 diabetes after the age of 15 years. In first-degree relatives aged under 40 years, we investigated the frequency of seroconversion to (persistent) Ab positivity, progression to diabetes and baseline characteristics of seroconverters according to age. Methods Abs against insulin (IAA), glutamate decarboxylase (GADA), insulinoma-associated protein 2 (IA-2A) and zinc transporter 8 (ZnT8A) were measured during follow-up of 7,170 first-degree relatives. Results We identified 379 (5.3%) relatives with positivity for IAA, GADA, IA-2A and/or ZnT8A (Ab+) at first sampling and 224 (3.1%) at a later time point. Most seroconversions occurred after the age of 10 years (63%). During follow-up, Abs persisted more often in relatives initially Ab+ (76%) than in seroconverters (53%; p < 0.001). In both groups diabetes developed at a similar pace and almost exclusively with Ab persistence (136 of 139 prediabetic individuals). For both groups, progression was more rapid if Abs appeared before the age of 10 years. Baseline characteristics at seroconversion did not vary significantly according to age. Conclusions/interpretation Seroconversion to (persistent) Ab+ occurs regardless of age. Although the progression rate to diabetes is higher under age 10 years, later seroconverters (up to age 40 years) have similar characteristics when compared with age-matched initially Ab+ relatives and generate an important minority of prediabetic relatives, warranting their identification and, eventually, enrolment in prevention trials.Keywords
This publication has 43 references indexed in Scilit:
- Development of Autoantibodies in the TrialNet Natural History StudyDiabetes Care, 2011
- Proinsulin and the proinsulin/insulin ratio in overweight and obese children and adolescents: relation to clinical parameters, insulin resistance, and impaired glucose regulationPediatric Diabetes, 2011
- Islet Autoantibody Seroconversion in the DPT-1 StudyDiabetes Care, 2011
- Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in ManDiabetes, 2011
- Enhancing the Understanding of Pre-Type 1 Diabetes in the General PopulationDiabetes Care, 2010
- Prediction of Type 1 Diabetes in the General PopulationDiabetes Care, 2010
- The Environmental Determinants of Diabetes in the Young (TEDDY) StudyAnnals of the New York Academy of Sciences, 2008
- The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetesProceedings of the National Academy of Sciences, 2007
- Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetesClinical and Experimental Immunology, 2007
- Transient Antiislet Autoantibodies: Infrequent Occurrence and Lack of Association with "Genetic" Risk FactorsThe Journal of Clinical Endocrinology & Metabolism, 2000